The DOI matches its Crossref record; 297 of the 299 references it cites were found in a registry or an index.
Master Regulators of Muscle Atrophy: Role of Costamere Components
Open accessAbstract
The loss of muscle mass and force characterizes muscle atrophy in several different conditions, which share the expression of atrogenes and the activation of their transcriptional regulators. However, attempts to antagonize muscle atrophy development in different experimental contexts by targeting contributors to the atrogene pathway showed partial effects in most cases. Other master regulators might independently contribute to muscle atrophy, as suggested by our recent evidence about the co-requirement of the muscle-specific chaperone protein melusin to inhibit unloading muscle atrophy development. Furthermore, melusin and other muscle mass regulators, such as nNOS, belong to costameres, the macromolecular complexes that connect sarcolemma to myofibrils and to the extracellular matrix, in correspondence with specific sarcomeric sites. Costameres sense a mechanical load and transduce it both as lateral force and biochemical signals. Recent evidence further broadens this classic view, by revealing the crucial participation of costameres in a sarcolemmal “signaling hub” integrating mechanical and humoral stimuli, where mechanical signals are coupled with insulin and/or insulin-like growth factor stimulation to regulate muscle mass. Therefore, this review aims to enucleate available evidence concerning the early involvement of costamere components and additional putative master regulators in the development of major types of muscle atrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another redox-sensitive transcription factor is nuclear factor kappa B (NF-κB), which dramatically increases muscle activity in sarcopenia, metabolic syndrome, and obesity [83, 113].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [113]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“The European Working Group on Sarcopenia in Older People defines sarcopenia by the presence of low appendicular lean mass/height2 and altered muscle strength, relative to sex-specific threshold values, and presarcopenia by the presence of decreased muscle mass without impact on muscle force development and contraction…”
BackgroundThe Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924 · cited 1×
“ATF4 protein synthesis increases in response to eIF-2-alpha phosphorylation consequent to PERK activation, and regulates gene expression of the transcription factor CHOP [56].”
BackgroundNitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797 · cited 3×
“The reduced S-nitrosylation of p53, secondary to a defective shuttle of nNOS to the nucleoskeleton, results in MuRF-1 gene upregulation [77], which is among the few atrogenes involved in sarcopenia [7,26].”
BackgroundAtrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774 · cited 1×
“The pioneering studies from Bodine’s and Goldberg’s laboratories [16,17] identified key genes, whose upregulation is shared in every of these conditions and leads to muscle atrophy development (the so-called atrogenes).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×
“Some reports suggest that chronic activation of p53 leads to premature myofiber aging associated with a significant atrophy [74,75].”
BackgroundIKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Autophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270 · cited 1×
“In line, the muscle wasting secondary to radiation therapy can be blocked by chemical inhibition of p53 [78].”
Background
Research works printed but not linked: 1
- Choi, S. (2018). Grp94 (HSP90B1). Encyclopedia of Signaling Molecules, Springer International Publishing.
Cited by
The critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
“Another redox-sensitive transcription factor is nuclear factor kappa B (NF-κB), which dramatically increases muscle activity in sarcopenia, metabolic syndrome, and obesity [83, 113].”
BackgroundDowling, P., Gargan, S., Murphy, S., Zweyer, M., Sabir, H., Swandulla, D., & Ohlendieck, K. (2021) · Proteomes · doi:10.3390/proteomes9010009 · Cited by 56
“Dystrophin-associated nitric oxide synthase, the enzyme responsible for the production of the key signaling molecule nitric oxide, was shown to play a regulatory role in costameres [132] and is involved in muscle fatigue, muscular atrophy and certain forms of muscular dystrophy [36,133,134].”
BackgroundGenetic Insights into Primary Restrictive Cardiomyopathy
Brodehl, A., & Gerull, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082094 · Cited by 47
Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy
Chen, R., Yuan, W., Zheng, Y., Zhu, X., Jin, B., Yang, T., Yan, Y., Xu, W., Chen, H., Gao, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01508-4 · Cited by 36
Aging, Osteo-Sarcopenia, and Musculoskeletal Mechano-Transduction
Leser, J. M., Harriot, A. D., Buck, H., Ward, C. W., & Stains, J. P. (2021) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2021.782848 · Cited by 33
Metadata
- Authors
- Gorza, L., Sorge, M., Seclì, L., & Brancaccio, M.
- Affiliations
- University of Padua (IT)
- University of Turin (IT)
- Corresponding author
- Gorza, Luisa
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-01-03
- Volume
- 10
- Issue
- 1
- Pages
- 61
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7823551
- OpenAlex
- W3120265875
- Cited by
- 31
- References
- 299
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 6 · 2021: 7
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- Università degli Studi di Padova (GORZ_FINA_P13_01)
- Università degli Studi di Torino (Ricerca Locale 2019)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- muscle atrophy, costameres, neuronal nitric oxide synthase, atrogenes, mechanical signaling, muscle mass regulation, insulin signaling, insulin-like growth factor, sarcolemma, extracellular matrix, transcription factors
- MeSH terms
- Animals, Humans, Models, Biological, Muscular Atrophy, Signal Transduction, Oxidative Stress, Mechanotransduction, Cellular, Costameres
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Master Regulators of Muscle Atrophy: Role of Costamere Components. https://app.cochat.ai/papers/10.3390/cells10010061
- The paper
- Gorza, L., Sorge, M., Seclì, L., & Brancaccio, M. (2021). Master Regulators of Muscle Atrophy: Role of Costamere Components. Cells. https://doi.org/10.3390/cells10010061
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.